chevron_leftBack
As of 24 April 2025, Olympus Corp. has a market cap of $14.34B USD, ranking #1292 globally and #94 in Japan. It ranks #110 in the Healthcare sector, and #15 in the Medical Devices industry.
Key Stats
Market Cap
$14.34BUSD
2.04T JPY
Enterprise Value
$14.37BUSD
2.06T JPY
Revenue (TTM)
$6.97BUSD
993.33B JPY
EBITDA (TTM)
$1.4BUSD
200.58B JPY
Net Income (TTM)
$587.67MUSD
83.74B JPY
EBITDA Margin
20%
Profit Margin
8.4%
PE Ratio
21.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Yasuo Takeuchi
open_in_new
Employees
28,838
Founded
1919
Website
olympus-global.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.8% | 0.6% | -7.8% | -22% | -36% | -17% |
Upcoming Earnings
Earnings Date
Tue, May 13
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
7733
オリンパス株式会社
ISIN: JP3201200007
Shares Out.:
Shares Outstanding:
1.089B1
Shares Float:
966.949M2
|
1.8K JPY | |
|
OCPNF
オリンパス株式会社
ISIN: JP3201200007
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
10.98 USD | |
|
OLYMY
オリンパス株式会社 ADR - Unsponsored
ISIN: US68163W2089
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
12.55 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Olympus Corp.
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.
